08 Dec 2008
New research is leading to improved survival rates for leukemia and non-Hodgkin's lymphoma, according to one expert.
Speaking at a press conference during the 50th Annual Meeting of the American Society of Hematology in San Francisco, USA, it was suggested that the latest studies had made "great advances" in the treatment of various blood cancers.
Dr Linda Burns, professor of medicine in the Division of Hematology, Oncology, and Transplantation at the University of Minnesota, Minneapolis, USA, said new data was proving positive in the fight against such conditions.
"By conducting ongoing research with new, investigational treatments as well as with different combinations of existing treatment options
we are working to improve the survival of our patients with leukemia and lymphoma," she said.
Leukemia and lymphoma are two of the most common types of blood cancers, with the former diagnosed on the speed at which they grow and the latter noted by their ability to damage the body's immune system.
The 50th Annual Meeting of the American Society of Hematology will be held in San Francisco between December 6th and 9th.
Click here to visit the non-Hodgkin's lymphoma Quick Guide
Delicious
Reddit
Facebook
StumbleUpon